###begin article-title 0
###xml 50 51 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 35 40 <span type="species:ncbi:9606">Human</span>
Gain-of-Function R225W Mutation in Human AMPKgamma3 Causing Increased Glycogen and Decreased Triglyceride in Skeletal Muscle
###end article-title 0
###begin p 1
Conceived and designed the experiments: LP RD RM MH. Performed the experiments: SC NK NA SC WS. Analyzed the data: LP RM MH SC NK NA SC WS. Contributed reagents/materials/analysis tools: LP RD RM MH. Wrote the paper: LP RD RM MH SC NK NA. Other: Designed the study: MH. Wrote the first draft of the paper: MH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 361 362 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 676 679 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hamilton1">[1]</xref>
###xml 680 683 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Scott1">[3]</xref>
###xml 775 776 767 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 101 106 <span type="species:ncbi:4932">yeast</span>
###xml 788 794 <span type="species:ncbi:9606">humans</span>
AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that is evolutionarily conserved from yeast to mammals and functions to maintain cellular and whole body energy homeostasis. Studies in experimental animals demonstrate that activation of AMPK in skeletal muscle protects against insulin resistance, type 2 diabetes and obesity. The regulatory gamma3 subunit of AMPK is expressed exclusively in skeletal muscle; however, its importance in controlling overall AMPK activity is unknown. While evidence is emerging that gamma subunit mutations interfere specifically with AMP activation, there remains some controversy regarding the impact of gamma subunit mutations [1]-[3]. Here we report the first gain-of-function mutation in the muscle-specific regulatory gamma3 subunit in humans.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 61 62 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 69 75 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 232 233 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 287 288 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 366 367 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 484 485 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 567 583 551 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
###xml 487 491 <span type="species:ncbi:9823">pigs</span>
We sequenced the exons and splice junctions of the AMPK gamma3 gene (PRKAG3) in 761 obese and 759 lean individuals, identifying 87 sequence variants including a novel R225W mutation in subjects from two unrelated families. The gamma3 R225W mutation is homologous in location to the gamma2R302Q mutation in patients with Wolf-Parkinson-White syndrome and to the gamma3R225Q mutation originally linked to an increase in muscle glycogen content in purebred Hampshire Rendement Napole (RN-) pigs. We demonstrate in differentiated muscle satellite cells obtained from the vastus lateralis of R225W carriers that the mutation is associated with an approximate doubling of both basal and AMP-activated AMPK activities. Moreover, subjects bearing the R225W mutation exhibit a approximately90% increase of skeletal muscle glycogen content and a approximately30% decrease in intramuscular triglyceride (IMTG).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 97 98 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 135 136 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 392 393 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 118 124 <span type="species:ncbi:9606">humans</span>
###xml 397 402 <span type="species:ncbi:9606">human</span>
We have identified for the first time a mutation in the skeletal muscle-specific regulatory gamma3 subunit of AMPK in humans. The gamma3R225W mutation has significant functional effects as demonstrated by increases in basal and AMP-activated AMPK activities, increased muscle glycogen and decreased IMTG. Overall, these findings are consistent with an important regulatory role for AMPK gamma3 in human muscle energy metabolism.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie1">[4]</xref>
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes1">[7]</xref>
###xml 495 503 495 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie1">[4]</xref>
###xml 688 691 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie2">[6]</xref>
###xml 818 821 818 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Kahn1">[5]</xref>
###xml 947 950 947 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Bergeron1">[8]</xref>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Winder1">[11]</xref>
###xml 103 108 <span type="species:ncbi:4932">yeast</span>
AMP-activated protein kinase (AMPK) is a serine/threonine kinase that is evolutionarily conserved from yeast to mammals and functions as a highly responsive energy sensor in cells [4]-[7]. It acts both centrally and peripherally to coordinate multiple inputs from various hormones, peptides and nutrients to maintain overall energy homeostasis. In response to cellular stress in the periphery, AMPK inhibits anabolic pathways and stimulates catabolic pathways to restore cellular energy charge. In vitro and experimental animal studies have demonstrated that altered activity of AMPK has significant implications for a number of cardiovascular risk factors, including type 2 diabetes [4]-[6]. In skeletal muscle, AMPK activation stimulates glucose uptake, fatty acid uptake and oxidation, and mitochondrial biogenesis [5]. Thus AMPK activation in skeletal muscle protects against the development of insulin resistance, type 2 diabetes and obesity [8]-[11].
###end p 9
###begin p 10
###xml 176 177 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 184 185 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 238 239 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 245 246 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 308 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 315 316 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 323 324 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 326 330 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Carling1">[12]</xref>
###xml 332 336 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Crute1">[13]</xref>
###xml 338 346 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g001">Figure 1</xref>
###xml 588 591 536 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Kahn1">[5]</xref>
###xml 705 706 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 776 780 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Mahlapuu1">[14]</xref>
###xml 960 976 896 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 1150 1154 1086 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Wojtaszewski1">[15]</xref>
###xml 1155 1159 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Nielsen1">[17]</xref>
###xml 1283 1299 1219 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 1306 1307 1238 1239 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1312 1313 1241 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1319 1320 1244 1245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1327 1328 1248 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1333 1334 1251 1252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1340 1341 1254 1255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1351 1352 1261 1262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1357 1358 1264 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1364 1365 1267 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1365 1369 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Birk1">[18]</xref>
###xml 1502 1503 1401 1402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1625 1629 1524 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Birk1">[18]</xref>
###xml 1640 1641 1535 1536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1672 1674 1563 1565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2L</sub>
###xml 1684 1686 1571 1573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2S</sub>
###xml 1785 1789 1672 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Cheung1">[19]</xref>
###xml 1790 1794 1677 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob1">[21]</xref>
###xml 1860 1862 1743 1745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2S</sub>
###xml 1897 1901 1780 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Cheung1">[19]</xref>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 903 909 <span type="species:ncbi:9606">humans</span>
###xml 1277 1282 <span type="species:ncbi:9606">human</span>
AMPK has a heterotrimeric structure and is composed of an alpha-catalytic, a beta-regulatory and a gamma-regulatory subunit. The alpha-catalytic subunit has two isoforms (alpha1, alpha2), the beta-regulatory subunit has two isoforms (beta1, beta2), and the gamma-regulatory subunit has three isoforms (gamma1, gamma2, gamma3) [12], [13]. Figure 1 depicts the three gamma isoforms and their structural characteristics. The various isoforms of each subunit are encoded by distinct genes, with alternative promoters and splice variants, adding to genetic and post-translational complexities [5]. Most isoforms are expressed to some extent in all tissues, although mRNA expression data indicate that the gamma3 subunit is more abundant in skeletal muscle than in any other tissue [14]. The relative proportions of the gamma subunits in human skeletal muscles are as yet unknown. Several exercise studies in humans have measured gamma subunit protein levels in the vastus lateralis muscle. In these studies, protein levels were expressed as percentage of sedentary controls, pretraining values, or untrained muscles as opposed to absolute relative values [15]-[17]. A more recent study provided evidence that only 3 out of the 12 possible AMPK complex combinations are expressed in human vastus lateralis: alpha1/beta2/gamma1, alpha2/beta2/gamma1 and alpha2/beta2/gamma3[18] . The only heterotrimer shown to be phosphorylated and activated during high intensity exercise was the complex containing the gamma3 isoform. The activity associated with the other two heterotrimers either remained unchanged or decreased during exercise [18]. The gamma2 long and short isoforms (gamma2L and gamma2S, respectively) result from alternative splicing of a common transcript in heart and other tissues [19]-[21]. While both long and short isoforms are expressed in heart, gamma2S is predominant in skeletal muscle [19].
###end p 10
###begin p 11
###xml 81 82 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 306 309 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Burwinkel1">[2]</xref>
###xml 311 314 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Scott1">[3]</xref>
###xml 316 320 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Dyck1">[22]</xref>
###xml 395 396 383 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 499 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Daniel1">[23]</xref>
###xml 662 666 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob1">[21]</xref>
###xml 668 672 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob2">[24]</xref>
###xml 674 678 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Arad1">[25]</xref>
###xml 779 780 763 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 872 876 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 953 954 933 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 991 994 971 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes1">[7]</xref>
###xml 58 64 <span type="species:ncbi:9606">humans</span>
###xml 724 728 <span type="species:ncbi:9823">pigs</span>
###xml 975 990 <span type="species:ncbi:10090">transgenic mice</span>
To date the only published mutations in the AMPK genes in humans are in the gamma2-regulatory subunit, the predominant gamma isoform in cardiac muscle. While AMPK activity stimulates fatty acid oxidation, glucose uptake and glycolysis in the heart, its regulation is complex, and still not well understood [2], [3], [22]. At least six different missense mutations within the CBS domains of gamma2 have been shown to cause the excess storage of glycogen in pronounced glycogen-associated vacuoles[23]. This excess storage of glycogen results in a complex phenotype, including Wolf-Parkinson-White (WPW) syndrome, conduction system disease and cardiac hypertrophy [21], [24], [25]. In purebred Hampshire Rendement Napole (RN) pigs, a naturally occurring R225Q mutation in the gamma3 subunit of AMPK was identified and linked to increased glycogen storage in skeletal muscle [26] and to increased resynthesis of glycogen after exercise when R225Q AMPKgamma3 is overexpressed in transgenic mice [7].
###end p 11
###begin p 12
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 310 311 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 353 354 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 477 493 469 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
In the context of our ongoing goal of identifying genes that underlie predisposition for diabetes and obesity, we searched for genetic variation in human PRKAG3. Of the 24 novel coding variants identified, we focused on the R225W mutation due to the established importance of the mutation in porcine AMPK gamma3 and the homologous mutations in the gamma2 subunit of human AMPK. We determined the functional significance of this mutation in differentiated muscle cells from the vastus lateralis of R225W carriers compared to matched controls.
###end p 12
###begin p 13
###xml 79 80 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 87 93 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Here we describe a previously unreported R225W mutation in the human AMPK gamma3 gene, PRKAG3, found in two independent kindreds. We show that the R225W mutation causes increased basal and AMP-activated AMPK activity, as well as increased muscle glycogen storage and decreased intramuscular triglyceride (IMTG).
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Subjects and Sequence Analysis
###end title 15
###begin p 16
###xml 61 62 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 393 394 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 401 403 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 491 492 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 499 501 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 836 840 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ahituv1">[27]</xref>
###xml 986 990 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ahituv2">[28]</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 713 725 <span type="species:ncbi:9606">participants</span>
###xml 869 876 <span type="species:ncbi:9606">patient</span>
The coding exons and splice junctions of the human AMPK gamma3 gene (NCBI accession no. NM_017431) were resequenced in obese Caucasian subjects from the Ottawa Hospital Weight Management Clinic and in lean healthy Caucasian individuals who participated in a study of leanness at the University of Ottawa Heart Institute. The cohorts consisted of 761 obese subjects with a mean BMI of 39.9 kg/m2 and>90th percentile adjusted for age and sex, and 759 lean subjects with a mean BMI of 20.1 kg/m2 and<25th percentile adjusted for age and sex. The study was approved by the institutional review boards of the University of Ottawa Heart Institute and the Ottawa Hospital. Informed written consent was obtained from all participants. A total of 58 genes were sequenced as part of this study and detailed findings have been presented elsewhere [27]. Selection criteria for our patient population as well as methods for DNA isolation, sequencing and data analysis have been described previously [28].
###end p 16
###begin p 17
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ramensky1">[29]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ng1">[30]</xref>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g001">Figure 1</xref>
###xml 466 467 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 735 743 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g002">Figure 2</xref>
###xml 945 952 941 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000903-t001">Table 1</xref>
###xml 378 382 <span type="species:ncbi:9823">pigs</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
Predictions of the possible functional implications of the variants were made using PolyPhen () and SIFT () programs [29], [30]. The R225W variant, which is found in the second CBS domain (Figure 1), was identified to be functionally damaging by both programs. This variant was intriguing since it is analogous to the R225Q mutation causing increased muscle glycogen content in pigs, as well as having the same amino acid location as the mutations in the human gamma2 subunit that are known to alter AMPK protein function and cause Wolf-Parkinson-White syndrome. We thus contacted subjects that were identified as carrying the R225W mutation in the initial study cohorts, and screened their available family members for further study (Figure 2). The region of the AMPKG3 gene with the R225W variation was sequenced in DNA samples from family members to determine whether they carried the same variation. Subject characteristics are described in Table 1.
###end p 17
###begin title 18
gamma subunit isoforms showing the 4 tandem repeats of CBS domains responsible for AMP and ATP binding.
###end title 18
###begin p 19
###xml 73 74 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 135 136 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 208 212 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Carling1">[12]</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Locations of the human R225W and the porcine R225Q mutations in the gamma3 subunit as well as the R302Q and R61Q mutations in the gamma2 long and short forms, respectively, are indicated. Figure adapted from [12].
###end p 19
###begin title 20
Families of the two probands with the PRKAG3-R225W mutation.
###end title 20
###begin p 21
*Subjects who underwent muscle biopsy.
###end p 21
###begin title 22
Characteristics of PRKAG3-R225W subjects and controls who underwent muscle biopsy.
###end title 22
###begin p 23
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
Blood chemistry measurements were conducted following an overnight fast. Means +/- SD. n = 5, Student's t-test, no significant differences between R225W and control subjects.
###end p 23
###begin title 24
Skeletal Muscle Biopsies and Cell Culture
###end title 24
###begin p 25
###xml 383 399 383 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 550 566 550 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vastus lateralis</italic>
###xml 721 722 717 718 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 746 750 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Birk1">[18]</xref>
###xml 603 608 <span type="species:ncbi:9606">human</span>
###xml 1370 1374 <span type="species:ncbi:9925">goat</span>
###xml 1380 1385 <span type="species:ncbi:10090">mouse</span>
###xml 1668 1673 <span type="species:ncbi:9796">horse</span>
Five subjects with the R225W mutation and five control subjects were matched for gender, age, weight, BMI, as well as amount and intensity of self-reported weekly physical activity. These subjects refrained from physical activity for three days prior to undergoing additional studies in the post-absorptive state after an overnight fast. Percutaneous skeletal muscle biopsies of the vastus lateralis muscle were obtained from R225W carriers and their matched controls using a 5 mm Bergstrom needle (Opitek) under local anaesthesia with 1% lidocaine. Vastus lateralis is commonly selected for studies of human muscle metabolism and was chosen for biopsy in the current study due to the demonstrated importance of the gamma3 subunit in this muscle [18]. A 10 mg sample of the biopsy was flash frozen in O.C.T. compound for muscle fiber typing, glycogen content determination and IMTG determination. A 25 mg sample of tissue was subjected to trypsin digestion and cells were grown to approximately70% confluency in Ham's F10 media (supplemented with 1% antibiotic-antimycotic, 2.5 microg/mL gentamycin, 12.4% FBS, 0.41 mg/mL BSA, 826 nM dexamethazone, 8.3 ng/mL epidermal growth factor, 0.41 mg/mL fetuin, and 25 pmol insulin). Isolation of satellite cells was achieved via immuno-sorting using primary anti-5.1H11 (Developmental Studies Hybridoma Bank) and secondary MACS goat anti-mouse IgG microbeads. After the suspension was passed through a magnetic field, labelled cells were isolated, eluted and then grown up in culture. Upon reaching 80% confluency, cells were differentiated for approximately10 days in Dulbecco's modified Eagle's medium (supplemented with 2% horse serum, 1% antibiotic-antimycotic and 2.5 microg/mL gentamycin).
###end p 25
###begin title 26
AMPK Isolation
###end title 26
###begin p 27
###xml 249 250 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 252 253 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 379 383 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ingham1">[31]</xref>
###xml 385 389 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie3">[32]</xref>
Approximately 10 days after differentiation, myotubes were incubated on ice while shaking in the presence of lysis buffer (30 mM HEPES, 2.5 mM EGTA, 3 mM EDTA, 70 mM KCl, 0.1% Nonidet P-40, 20 mM beta-glycerophosphate, 20 mM NaF, 2 mM NaPPi, 1 mM Na3VO4, 200 microM PMSF and 1 microM pepstatin A). Partial purification of AMPK from the cell lysate was carried out as detailed in [31], [32]. The cell lysate was incubated at a 1:1 ratio with 30% polyethylene glycol 6000 for 1 hour. Resulting purified protein was dissolved in assay buffer (62.5 mM Na HEPES, 62.5 mM NaCl, 62.5 mM NaF, 6.25 mM Na pyrophosphate, 1.25 mM EDTA, 1.25 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF, 5 microg/mL SBTI and 1 microM pepstatin A) and then quantified using the bicinchoninic assay.
###end p 27
###begin title 28
AMPK Activity Determination
###end title 28
###begin p 29
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie3">[32]</xref>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Davies1">[33]</xref>
###xml 266 268 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 565 567 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
The SAMS peptide assay was carried out as detailed in [32], [33] with minor modifications: 13 microL reaction buffer (20 mM HEPES-NaOH, 0.4 mM dithiothreitol, 0.01% Brij-35 with or without 300 microM AMP), 10 microL of 562 microM SAMS substrate peptide, 10 microCi [32P]ATP (3000 Ci/mmol), and 6 microg of partially purified AMPK were incubated with constant shaking at 30degreesC for 15 minutes. Negative controls consisted of all reagents except SAMS substrate peptide and AMP. All reactions were carried out in triplicate. AMPK activity was expressed as pmol of 32P-radiolabeled phosphate incorporated into the SAMS peptide per minute per mg of protein.
###end p 29
###begin title 30
Quantitative RT-PCR Analysis
###end title 30
###begin p 31
RNA from muscle biopsy samples was extracted using Trizol (Invitrogen) and treated with DNaseI (Ambion). cDNA was generated from 0.5 microg of RNA using random decamer primers (Ambion) with MMLV reverse transcriptase (Invitrogen). Amplicons of AMPKG3 and GAPDH genes were cloned into pCR 2.1-TOPO (Invitrogen). Serial dilutions of these constructs were used to generate standard curves, following assessment of primer efficiency and analysis of melting curve profiles. Quantitative real-time PCR analysis was performed in a LightCycler system (Roche) using FastStart DNA MasterPLUS SYBR Green I kit (Roche). The primers for real-time PCR were designed using LightCycler Probe Design Software v1.0 (Roche). Following 30 cycles of amplification with 1.0 microl of cDNA and 0.5 microM of F and R primers per reaction, expression of AMPKG3 was normalized to expression of GAPDH. Primer sequences: F: 5'-CAGAGGACACTATGTCTGG-3' and R: 5'-GCTTGGGATTGAGGACT-3' (AMPKG3), F: 5'-GATTTGGCCGTATTGGG-3' and R: 5'-TCCACGACATACTCAGC-3' (GAPDH).
###end p 31
###begin title 32
Western Blotting and Densitometry
###end title 32
###begin p 33
###xml 40 41 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 363 364 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 375 376 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 505 509 <span type="species:ncbi:9925">goat</span>
###xml 515 521 <span type="species:ncbi:9986">rabbit</span>
To determine protein levels of the gamma3 isoform, the same purified protein extracts that were used for the AMPK activity assay were subjected to immunoblotting. Electrophoresis was carried out using a 12% polyacrylamide gel. Following transfer to nitrocellulose membranes, primary antibodies were incubated at a 1:1000 dilution overnight at 4degreesC (AMPKgamma1, AMPKgamma3 and beta-actin antibodies were from Cell Signaling Technology, Danvers, MA). The secondary antibody was a peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz Inc., Santa Cruz, CA) and was incubated at a 1:500 dilution for one hour at room temperature. For detection, blots were processed using enhanced chemiluminescence kits (Amersham Pharmacia; Baie d'Urfe, QC, Canada). beta-actin was used as the loading control and densitometry was carried out to determine relative protein levels (values expressed as gamma isoform integrated densitometry value (IDV) divided by beta-actin IDV).
###end p 33
###begin title 34
Muscle Glycogen Content Determination
###end title 34
###begin p 35
###xml 455 462 <span type="species:ncbi:9606">patient</span>
Glycogen content was determined using Periodic Acid Schiff (PAS) staining. Frozen tissues were cut as 10 microm cross sections and mounted on Superfrost slides. After Schiff staining, sections were counterstained with Harris's hematoxylin. Imaging software (Northern Eclipse) was used to analyze tissues at 200x magnification with an Axiophot digital light microscope (Axiophot 2, Zeiss, Oberkochen, Germany). 2-3 fields of view in each of 3 sections per patient were analyzed for glycogen content as a proportion of surface area of each field.
###end p 35
###begin title 36
Intramuscular Triglyceride (IMTG) Content
###end title 36
###begin p 37
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 231 232 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 517 524 <span type="species:ncbi:9606">patient</span>
lMTG content was determined using osmium tetroxide (OsO4) staining. Frozen tissues were cut as 10 microm cross sections and mounted on Superfrost slides and fixed in 10% neutral buffered formalin. IMTG was stained black with 1% OsO4 and then cells were counterstained with hematoxylin and eosin (H&E). Imaging software (Northern Eclipse) was used to analyze tissues at 200x magnification with an Axiophot digital light microscope (Axiophot 2, Zeiss, Oberkochen, Germany). 2-3 fields of view in each of 3 sections per patient were analyzed for IMTG content as a proportion of surface area of each field.
###end p 37
###begin title 38
Fiber Typing
###end title 38
###begin p 39
###xml 397 401 <span type="species:ncbi:9925">goat</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 1068 1075 <span type="species:ncbi:9606">patient</span>
Frozen tissues were cut as 10 microm cross sections and mounted on Superfrost slides. Sections were stained using the Vectastain ABC-AP kit (Vector Laboratories). Type 1 fibers were identified by using A4.840 as the primary antibody (Developmental Studies Hybridoma Bank), which is specific to the C-terminal part of the beta slow myosin heavy chain in type I skeletal muscle fibers. Biotinylated goat anti-mouse IgG (BA-9200, Vector Laboratories) was used as the secondary antibody, and then cells were stained red using SK-5100 (Vector Laboratories). Type 2a fibers were identified by using N2.261 as the primary antibody (Developmental Studies Hybridoma Bank), which is specific to the N-terminal part of the beta slow myosin heavy chain in adult skeletal myosin heavy chain type IIA. BA-9200 was used as the secondary antibody, and then cells were stained blue using SK-5300 (Vector Laboratories). Type 2b/x fibers were identified as unstained cells. Fiber type ratios were determined by counting numbers of each fiber type in 2-3 fields of view in 3 sections per patient.
###end p 39
###begin title 40
Statistical Analysis
###end title 40
###begin p 41
###xml 226 234 226 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g003">Figure 3</xref>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 371 380 371 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g004">Figures 4</xref>
###xml 381 381 381 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g005"/>
###xml 381 381 381 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g006"/>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g007">7</xref>
The management of clinical and genotypic data was carried out with SAS statistical software (Version 9.1, SAS Institute Inc., Cary, NC). A one-way ANOVA with Tukey post-test was used to determine differences in AMPK activity (Figure 3). Student's t tests were used to assess mRNA levels, protein levels, glycogen content, intramuscular triglyceride and fiber type ratio (Figures 4-7).
###end p 41
###begin title 42
Basal and AMP-activated AMPK activities in differentiated skeletal muscle cells from R225W carriers and matched control subjects.
###end title 42
###begin p 43
Means +/- SD. n = 3, One-way ANOVA, Tukey post-test, *p = 0.015, **p = 0.001.
###end p 43
###begin title 44
###xml 36 37 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 51 52 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Relative protein levels of the gamma1 (A) and gamma3 (B) isoforms in differentiated skeletal muscle cells from R225W carriers and matched control subjects.
###end title 44
###begin p 45
###xml 155 156 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The integrated densitometry value (IDV) for each gamma subunit was divided by the IDV of the loading control, beta-actin. Means +/- SD. n = 2-4, Student's t-test, p = 0.389 (A), p = 0.229 (B).
###end p 45
###begin title 46
###xml 20 36 20 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
Glycogen content of vastus lateralis for R225W and control subjects.
###end title 46
###begin p 47
###xml 72 79 72 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Muscle sections were prepared and stained with PAS, as described in the methods section (A: control, B: R225W). C: quantification of glycogen content via imaging software. Means +/- SD. n = 5, Student's t-test, **p = 0.002.
###end p 47
###begin title 48
###xml 38 54 38 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
Intramuscular triglyceride content of vastus lateralis for R225W and control subjects.
###end title 48
###begin p 49
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 73 80 73 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Muscle sections were prepared and stained with OsO4, as described in the methods section (A: control, B: R225W). C: quantification of IMTG via imaging software. Means +/- SD. n = 4, Student's t-test, *p = 0.032.
###end p 49
###begin title 50
###xml 21 37 21 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
Fiber type ratios of vastus lateralis for R225W versus control subjects, expressed as percentage of each fiber type
###end title 50
###begin p 51
###xml 33 35 33 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
. Means +/- SD. n = 5, Student's t-test for each fiber type, no significant differences between R225W and control subjects (Type 1: p = 0.992, Type 2a: p = 0.896, Type 2b/x: p = 0.834).
###end p 51
###begin title 52
Results
###end title 52
###begin title 53
###xml 10 11 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
AMPK gamma3 Sequence Variants
###end title 53
###begin p 54
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 381 387 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 942 949 942 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000903-t002">Table 2</xref>
###xml 968 974 968 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 1165 1169 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ramensky1">[29]</xref>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Ng1">[30]</xref>
We sequenced the exons and intron/exon boundaries of PRKAG3, which codes for the subunit of AMPK that is specific to skeletal muscle. We studied 761 obese subjects with a mean BMI of 39.9 kg/m2 and>90th percentile adjusted for age and gender, and 759 lean subjects with a mean BMI of 20.1 kg/m2 and<25th percentile adjusted for age and gender. We identified 87 genetic variants in PRKAG3 and its flanking regions. Of the six common (minor allele frequency>0.05) variants, three were intronic polymorphisms (IVS2+45, IVS6+31 and IVS10+85), one was a synonymous variant (G180G), and two were non-synonymous variants (P71A and R340W). The 81 rare variants included one SNP in the upstream region, one in the 5' UTR, 50 intronic SNPs, 10 synonymous and 16 nonsynonymous coding variants, one frameshift mutation that leads to a stop codon and two SNPs in the 3' UTR. The frequency and functional prediction for the coding variants are outlined in Table 2. Of the 30 coding PRKAG3 variants observed in this study, 24 were not listed in the current SNP database (dbSNPbuild126). Computational predictions of the severity of missense substitutions were made using PolyPhen [29] and SIFT [30].
###end p 54
###begin title 55
Coding variants in the PRKAG3 gene observed in this study.
###end title 55
###begin p 56
(MAF: minor allele frequency; S/NS: synonymous/nonsynonymous)
###end p 56
###begin p 57
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 101 105 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 107 111 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Andersson1">[34]</xref>
###xml 113 117 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hedegaard1">[35]</xref>
###xml 134 135 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 175 179 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob1">[21]</xref>
###xml 491 499 483 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g002">Figure 2</xref>
###xml 621 628 613 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000903-t002">Table 2</xref>
###xml 82 86 <span type="species:ncbi:9823">pigs</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
Given the established importance of homologous mutations in Rendement Napole (RN-)pigs (gamma3R225Q) [26], [34], [35] and in the gamma2 subunit (R302Q/R61Q) in human patients [21], we pursued the functional significance of the novel R225W mutation identified in two unrelated subjects. A total of 11 subjects from the two families were screened for the R225W mutation. Two family members in the first family and three family members in the second family were observed to carry the mutation (Figure 2). Other sequence variants that are predicted to have functional implications according to PolyPhen and SIFT are shown in Table 2. Of interest are variants M197T, I269T, R307C and R340Q, all of which occur at similarly low frequencies in our cohorts.
###end p 57
###begin title 58
Characteristics of R225W and Matched Control Subjects
###end title 58
###begin p 59
###xml 425 433 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g002">Figure 2</xref>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000903-t001">Table 1</xref>
###xml 872 874 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
The five carriers of the R225W variant were matched with control subjects on the basis of gender, age, weight, and BMI. The R225W carriers and control subjects were also well-matched for amount and intensity of self-reported weekly physical activity. Two brothers of the proband in the first family, and the sister and daughter of the proband in the second family consented to muscle biopsies and were included in the study (Figure 2). No significant differences were noted in fasting values for plasma lipids, glucose, insulin,or HbA1C in this small cohort (Table 1). During a hyperinsulinemic glucose clamp study, the rate of glucose infusion required to maintain euglycemia in the last hour of the clamp was somewhat higher in the 2 carriers of the R225W variant as compared to 2 closely matched controls but did not reach a nominal standard of significance (7.3+/-0.8 vs. 5.4+/-2.4 ml/kg/min, p = 0.16).
###end p 59
###begin title 60
Basal and AMP-Activated AMPK Activity
###end title 60
###begin p 61
###xml 100 116 100 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie3">[32]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Davies1">[33]</xref>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g003">Figure 3</xref>
We determined that the R225W mutation had an overall effect on AMPK activity. Myocytes derived from vastus lateralis biopsies were immunopurified and differentiated into myotubes, following which total AMPK activity was assayed using the 'gold-standard' SAMS peptide assay [32], [33] in purified protein extracts. Results demonstrated that the basal (p = 0.015) as well as the AMP-activated (p = 0.001) AMPK activities in subjects with the R225W mutation were two-fold higher compared to that found in controls (Figure 3). Control subjects exhibited a 0.054 pmol/min/mg mean increase in activity upon AMP-stimulation, whereas R225W carriers showed a mean increase of 0.108 pmol/min/mg, representing a 65% and a 58% increase from basal activity, respectively. Although R225W carriers demonstrate twice the AMP-stimulated AMPK activity of control subjects, the similar percent increases indicate that R225W AMPK is likely activated by AMP with a similar magnitude to control AMPK. R225W AMPK is therefore not constitutively active or AMP-independent, as it is able to be further activated by AMP.
###end p 61
###begin title 62
Expression of AMPK gamma Isoforms
###end title 62
###begin p 63
###xml 9 10 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 127 128 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 224 225 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 235 236 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 520 521 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 530 531 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 632 647 605 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g004">Figure 4a and b</xref>
###xml 739 755 712 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 765 766 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 770 771 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 776 777 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 784 785 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 789 790 744 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 795 796 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 806 807 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 812 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 817 818 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 818 822 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Birk1">[18]</xref>
###xml 952 958 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 733 738 <span type="species:ncbi:9606">human</span>
AMPKgamma3 mRNA levels in skeletal muscle biopsy samples were detected by RT-PCR analysis. There was no difference in AMPKgamma3 mRNA levels between R225W carriers and control subjects (p = 0.083, 2-tailed t-test). AMPKgamma1 and gamma3 protein levels were detected by Western blotting in the same purified protein extracts as used for the AMPK activity assay. beta-actin was used as the loading control and densitometry was carried out to determine relative protein levels. There were no differences in either AMPKgamma1 or gamma3 protein levels between R225W carriers and control subjects (p = 0.389 and p = 0.229, respectively) (Figure 4a and b). Importantly, the only three complexes that normally contribute to AMPK activity in human vastus lateralis are alpha1beta2gamma1, alpha2beta2gamma1 and alpha2beta2gamma3[18]. We believe that the R225W variant is affecting AMPK activity without affecting the level of transcription or translation of the PRKAG3 gene.
###end p 63
###begin title 64
Skeletal Muscle Glycogen Content
###end title 64
###begin p 65
###xml 145 161 145 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g005">Figure 5</xref>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 370 371 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 424 428 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 341 345 <span type="species:ncbi:9823">pigs</span>
To determine the effect of the R225W mutation on skeletal muscle glycogen content, we used Periodic Acid Schiff (PAS) staining of cryo-sectioned vastus lateralis muscle. As shown in Figure 5, muscle of R225W carriers had approximately 90% more muscle glycogen content than controls (p = 0.002). This result was expected as the Hampshire RN- pigs carrying the R225Q gamma3AMPK mutation have increased muscle glycogen content [26].
###end p 65
###begin title 66
Intramuscular Triglyceride (IMTG) Content
###end title 66
###begin p 67
###xml 188 189 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 219 222 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes1">[7]</xref>
###xml 245 246 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 276 292 272 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 395 403 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g006">Figure 6</xref>
###xml 120 135 <span type="species:ncbi:10090">transgenic mice</span>
We hypothesized that IMTG would be reduced in skeletal muscle of subjects with the R225W variant, given observations in transgenic mice expressing the homologous mutation in the AMPK gamma3 gene and fed a high fat diet [7]. Osmium tetroxide (OsO4) staining of sections of the vastus lateralis muscle indicated lower IMTG levels in the R225W carriers as compared to matched controls (p = 0.032) (Figure 6).
###end p 67
###begin title 68
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vastus Lateralis</italic>
Vastus Lateralis Muscle Fiber Type Composition
###end title 68
###begin p 69
###xml 273 281 273 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g007">Figure 7</xref>
Finally, we determined whether or not there were differences in muscle fiber type composition in the biopsied muscle. Immunohistochemistry of the sections revealed a similar proportional distribution of fiber types in subjects with the R225W mutation compared to controls (Figure 7). Fiber type ratio is an important measure due to its influence on muscle glycogen content and IMTG content. Since there are no differences in fiber type ratio between R225W subjects and controls, differences in glycogen and IMTG cannot be attributed to fiber type composition.
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 258 259 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 501 504 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie1">[4]</xref>
###xml 505 508 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hardie2">[6]</xref>
###xml 510 514 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Dyck1">[22]</xref>
###xml 707 711 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Cheung1">[19]</xref>
###xml 713 717 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Daniel1">[23]</xref>
###xml 719 723 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Arad1">[25]</xref>
###xml 725 729 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 731 735 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Yu1">[36]</xref>
###xml 831 832 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 996 1012 980 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 1026 1034 1010 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g003">Figure 3</xref>
###xml 1051 1052 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1062 1063 1038 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1112 1120 1088 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g004">Figure 4</xref>
###xml 1141 1157 1117 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 1215 1216 1187 1188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1220 1221 1189 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1226 1227 1191 1192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1234 1235 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1239 1240 1197 1198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1245 1246 1199 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1256 1257 1206 1207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1261 1262 1208 1209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1267 1268 1210 1211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1268 1272 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Birk1">[18]</xref>
###xml 1478 1486 1421 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g005">Figure 5</xref>
###xml 1516 1524 1459 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g006">Figure 6</xref>
###xml 1587 1595 1530 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000903-g007">Figure 7</xref>
###xml 844 850 <span type="species:ncbi:9606">humans</span>
###xml 1135 1140 <span type="species:ncbi:9606">human</span>
AMPK is widely recognized as a key metabolic regulator of energy expenditure in peripheral tissues and of energy intake in the hypothalamus. In this study we focused on the functional importance of a rare mutation in PRKAG3 encoding the AMPK regulatory gamma3 subunit that is expressed exclusively in skeletal muscle. While the functions of the three AMPK subunits have not been fully characterized, it is becoming increasingly clear that the gamma subunit is a major regulator of holoenzyme activity [4]-[6], [22]. The gamma subunit is thought to be involved in AMP binding, and in the regulation of glycogen content as variants in its CBS domains affect glycogen metabolism in skeletal and cardiac muscle [19], [23], [25], [26], [36]. This is the first report of functional effects of nonsynonymous sequence variants in the gamma3 subunit in humans. We have demonstrated that the R225W mutation increases basal and AMP-activated AMPK activities in differentiated muscle cells obtained from the vastus lateralis of carriers (Figure 3), and that gamma1 and gamma3 protein levels are unchanged in R225W carriers (Figure 4). Normally in human vastus lateralis, the complexes that contribute to AMPK activity are alpha1beta2gamma1, alpha2beta2gamma1 and alpha2beta2gamma3[18]. Future studies will need to assess the subunit combinations that contribute to AMPK activity in R225W carriers. We have also demonstrated that R225W results in increased skeletal muscle glycogen content (Figure 5) and decreased IMTG content (Figure 6), while there was no change in muscle fiber type composition (Figure 7).
###end p 71
###begin p 72
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 214 215 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 225 229 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 231 235 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Andersson1">[34]</xref>
###xml 237 241 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hedegaard1">[35]</xref>
###xml 264 265 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 271 275 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Fujii1">[37]</xref>
###xml 277 281 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes2">[38]</xref>
###xml 487 488 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 525 526 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 532 536 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Milan1">[26]</xref>
###xml 538 542 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Andersson1">[34]</xref>
###xml 670 671 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 972 973 956 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 1311 1315 1295 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Andersson1">[34]</xref>
###xml 1317 1321 1301 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Hedegaard1">[35]</xref>
###xml 186 190 <span type="species:ncbi:9823">pigs</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 310 315 <span type="species:ncbi:9606">human</span>
###xml 527 531 <span type="species:ncbi:9823">pigs</span>
###xml 974 978 <span type="species:ncbi:9823">pigs</span>
###xml 1151 1155 <span type="species:ncbi:9823">pigs</span>
###xml 1261 1265 <span type="species:ncbi:9823">pigs</span>
###xml 1458 1463 <span type="species:ncbi:9606">human</span>
Further studies are required to characterize the effects of R225W on metabolic responses to challenges such as acute and chronic exercise. However, given the literature on Hampshire RN- pigs with an analogous gamma3 mutation [26], [34], [35], and the Tg-R225Qgamma3 mice [37], [38], it is anticipated that the human R225W variant would result in improved capacity during chronic exercise challenges due to their increased muscle glycogen. The natural occurrence of mutations in AMPKgamma3 was first discovered in Hampshire RN- pigs [26], [34]. The single missense mutation, arginine 225 to glutamine (R225Q) results in a dominant mutation that is homologous to the gamma3 R225W variant described here. R225Q causes an approximate 70% increase in skeletal muscle glycogen, but no change in heart and liver glycogen content, resulting in poor meat quality. Other phenotypic effects include lower muscle fat content and increased oxidative capacity. Furthermore, Hampshire RN- pigs carrying the mutation showed normal resting levels of glucose and insulin as well as normal glucose tolerance tests. When challenged with exercise, it was found that R225Q pigs depleted their glycogen stores at normal rates, but re-synthesized glycogen at faster rates than control pigs due to increased muscle glucose uptake rates [34], [35]. This limited evidence indicated no functional impairments associated with the increased glycogen in skeletal muscle. Our findings that human R225W carriers have an approximate 90% increase in skeletal muscle glycogen, an approximate 30% decrease in intramuscular triglyceride, and normal levels of plasma lipids, glucose, insulin and HbA1C are consistent with the animal studies described above. Future studies will investigate the physiological response of these subjects to exercise challenges.
###end p 72
###begin p 73
###xml 53 54 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 206 209 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes1">[7]</xref>
###xml 420 423 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes1">[7]</xref>
###xml 546 550 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Yu1">[36]</xref>
###xml 696 709 692 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius</italic>
###xml 875 879 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Barnes2">[38]</xref>
###xml 933 934 925 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1156 1157 1144 1145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1206 1207 1190 1191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1354 1355 1334 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1359 1360 1336 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1365 1366 1338 1339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1373 1374 1342 1343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1378 1379 1344 1345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1384 1385 1346 1347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1395 1396 1353 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1400 1401 1355 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1406 1407 1357 1358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1453 1469 1404 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vastus lateralis</italic>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 139 142 <span type="species:ncbi:9823">pig</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 584 590 <span type="species:ncbi:9606">humans</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 947 953 <span type="species:ncbi:9606">humans</span>
###xml 1447 1452 <span type="species:ncbi:9606">human</span>
Recently mice bearing the homologous human AMPK gamma3 transgene, Tg-R225Q, were developed to study the effects of the naturally occurring pig mutation. The R225Q mutation produced a fully dominant protein [7] with increased AMPK activity. ACC phosphorylation was increased in the basal state as well as after stimulation with AICAR (an artificial activator of AMPK), indicating that the mutated AMPK could be activated [7]. Glycogen content of various muscles in mice bearing the R225Q mutation have 1.5-2 times the glycogen content of controls [36], consistent with our findings in humans. Moreover, exercise increased ACC phosphorylation and decreased intramuscular triglyceride (IMTG) in the gastrocnemius muscle of transgenic, compared to wild-type, mice. Tg-R225Q mice thus oxidized more fat in the AMP-stimulated state (during exercise) compared to wild-type controls [38]. As demonstrated in the current study, the R225Wgamma3 mutation in humans is a gain-of-function mutation that exhibits increased basal and AMP-activated activity of AMPK. It should be noted that total cellular AMPK activity was assayed in this study, not immuno-purified gamma3 activity. Therefore, the R225W mutation in gamma3 has an important effect overall on total AMPK activity in skeletal muscle. It will be of interest in future studies to determine whether the alpha1beta2gamma1, alpha2beta2gamma1 and alpha2beta2gamma3 subunit combinations normally found in human vastus lateralis are also formed in skeletal muscle of R225W carriers.
###end p 73
###begin p 74
###xml 60 61 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 145 149 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob1">[21]</xref>
###xml 151 155 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Gollob2">[24]</xref>
###xml 157 161 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Arad1">[25]</xref>
###xml 334 338 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Dyck1">[22]</xref>
###xml 390 391 382 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 491 495 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Daniel1">[23]</xref>
###xml 636 640 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Daniel1">[23]</xref>
###xml 738 739 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 844 845 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1026 1030 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Arad1">[25]</xref>
###xml 1068 1069 1048 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1202 1203 1178 1179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 883 888 <span type="species:ncbi:4932">yeast</span>
Interestingly, this novel mutation is analogous to the gamma2 subunit mutation that causes inherited cardiac arrhythmias and cardiac hypertrophy [21], [24], [25]. While it is known that AMPK activity stimulates fatty acid oxidation, glucose uptake and glycolysis in the heart, its regulation is complex, and still not well understood [22]. Missense mutations within the CBS domains of gamma2 have been shown to cause the excess storage of glycogen in pronounced glycogen-associated vacuoles [23]. This excess storage of glycogen is thought to result in myocyte hypertrophy, and gives rise to WPW syndrome and cardiac conduction disease [23]. The enhanced skeletal muscle glycogen deposition demonstrated in carriers of the analogous gamma3 mutation is consistent with the above results in the heart. Subsequent introduction of some of the gamma2 mutations into the AMPK homologue in yeast (SNF1/SNF4) produced a constitutively active enzyme, indicating that these heterozygous missense mutations were dominant in their effect [25]. Our findings indicate that the gamma3 R225W mutation increases basal AMPK activity, but results in a protein that can be further activated by AMP, unlike the latter gamma2 mutations.
###end p 74
###begin p 75
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRKAG3</italic>
###xml 366 367 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 608 612 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Zhou1">[39]</xref>
###xml 613 617 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000903-Musi1">[41]</xref>
###xml 44 49 <span type="species:ncbi:9606">human</span>
In summary, we report the identification of human subjects bearing a R225W mutation in PRKAG3 which causes increased basal and AMP-stimulated AMPK activity, increased glycogen content and decreased IMTG in skeletal muscle. These findings are relevant to an improved understanding of the regulatory role that AMPK plays in skeletal muscle energy metabolism. The gamma3 subunit represents an attractive pharmacological target due to its exclusive expression in skeletal muscle. It has already been demonstrated that Metformin, commonly prescribed for treatment of type 2 diabetes, acts via stimulation of AMPK [39]-[41]; and although it is not possible to draw conclusions regarding therapeutics from this study, it is tempting to hypothesize that the stimulation of AMPK activity in skeletal muscle alone, without affecting AMPK activity in the brain or heart, could be effective in the treatment of obesity and type 2 diabetes mellitus.
###end p 75
###begin p 76
###xml 110 117 <span type="species:ncbi:9606">patient</span>
We would like to thank Linda Jui for histochemistry work, Heather Doelle, Brenda Bradley and Sybil Hebert for patient recruitment and assistance with clinical studies, Thet Naing for technical assistance, and Dr. Michael Gollob for critically reading the manuscript. The authors would also like to express their sincere thanks to the subjects who participated in this research.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
An activating mutation in the gamma1 subunit of the AMP-activated protein kinase.
###end article-title 78
###begin article-title 79
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
###end article-title 79
###begin article-title 80
CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.
###end article-title 80
###begin article-title 81
The AMP-activated protein kinase-fuel gauge of the mammalian cell?
###end article-title 81
###begin article-title 82
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
###end article-title 82
###begin article-title 83
AMPK: a key sensor of fuel and energy status in skeletal muscle.
###end article-title 83
###begin article-title 84
The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle.
###end article-title 84
###begin article-title 85
###xml 139 143 <span type="species:ncbi:10116">rats</span>
Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
###end article-title 85
###begin article-title 86
###xml 91 95 <span type="species:ncbi:10116">rats</span>
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome.
###end article-title 86
###begin article-title 87
###xml 149 152 <span type="species:ncbi:10116">rat</span>
Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
###end article-title 87
###begin article-title 88
AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.
###end article-title 88
###begin article-title 89
The AMP-activated protein kinase cascade-a unifying system for energy control.
###end article-title 89
###begin article-title 90
Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase.
###end article-title 90
###begin article-title 91
Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle.
###end article-title 91
###begin article-title 92
###xml 45 50 <span type="species:ncbi:9606">human</span>
5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes.
###end article-title 92
###begin article-title 93
###xml 103 108 <span type="species:ncbi:9606">human</span>
5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle.
###end article-title 93
###begin article-title 94
###xml 84 89 <span type="species:ncbi:9606">human</span>
5'-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle.
###end article-title 94
###begin article-title 95
###xml 67 72 <span type="species:ncbi:9606">human</span>
Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle.
###end article-title 95
###begin article-title 96
Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.
###end article-title 96
###begin article-title 97
###xml 135 140 <span type="species:ncbi:9606">human</span>
Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36.
###end article-title 97
###begin article-title 98
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
###end article-title 98
###begin article-title 99
AMPK alterations in cardiac physiology and pathology: enemy or Ally?
###end article-title 99
###begin article-title 100
Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.
###end article-title 100
###begin article-title 101
Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
###end article-title 101
###begin article-title 102
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
###end article-title 102
###begin article-title 103
###xml 64 67 <span type="species:ncbi:9823">pig</span>
A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.
###end article-title 103
###begin article-title 104
###xml 38 43 <span type="species:ncbi:9606">human</span>
Medical sequencing at the extremes of human body mass.
###end article-title 104
###begin article-title 105
###xml 29 34 <span type="species:ncbi:9606">human</span>
A PYY Q62P variant linked to human obesity.
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human non-synonymous SNPs: server and survey.
###end article-title 106
###begin article-title 107
###xml 15 20 <span type="species:ncbi:9606">human</span>
Accounting for human polymorphisms predicted to affect protein function.
###end article-title 107
###begin article-title 108
Precipitation of proteins with polyethylene glycol.
###end article-title 108
###begin article-title 109
Analysis of the role of the AMP-activated protein kinase in the response to cellular stress.
###end article-title 109
###begin article-title 110
Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay.
###end article-title 110
###begin article-title 111
###xml 69 72 <span type="species:ncbi:9823">pig</span>
Identification and characterization of AMPK gamma 3 mutations in the pig.
###end article-title 111
###begin article-title 112
UDP-glucose pyrophosphorylase is upregulated in carriers of the porcine RN- mutation in the AMP-activated protein kinase.
###end article-title 112
###begin article-title 113
Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
###end article-title 113
###begin article-title 114
AMP-activated protein kinase and the regulation of glucose transport.
###end article-title 114
###begin article-title 115
###xml 123 127 <span type="species:ncbi:10090">Mice</span>
Changes in Exercise-Induced Gene Expression in 5'-AMP-Activated Protein Kinase {gamma}3-Null and {gamma}3 R225Q Transgenic Mice.
###end article-title 115
###begin article-title 116
Role of AMP-activated protein kinase in mechanism of metformin action.
###end article-title 116
###begin article-title 117
The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.
###end article-title 117
###begin article-title 118
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
###end article-title 118
###begin p 119
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 119
###begin p 120
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by a grant (#NA-5413) from the Heart and Stroke Foundation of Ontario (to R. McPherson and M-E Harper) and was partially conducted at the E.O. Lawrence Berkeley National Laboratory, and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.
###end p 120

